Nicotinic Acetylcholine Receptor beta (CHRNB1) (N-Term) Peptide
Quick Overview for Nicotinic Acetylcholine Receptor beta (CHRNB1) (N-Term) Peptide (ABIN8106490)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- CHRNB1 Peptide - N-terminal region
-
Sequence
- PLAPGVRGSE AEGRLREKLF SGYDSSVRPA REVGDRVRVS VGLILAQLIS
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-ACHB Antibody (ARP34969_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CHRNB1 (Nicotinic Acetylcholine Receptor beta (CHRNB1))
-
Background
-
Background Information: The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome.
Alternative Symbols: ACHRB, CHRNB, CMS1D, CMS2A, CMS2C, SCCMS
-
Molecular Weight
- 55kDa
-
Gene ID
- 1140
-
NCBI Accession
- NP_000738
-
UniProt
- P11230
Target
-